ABIO insider filings

ARCA biopharma, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2024-08-30. Screen ABIO transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ABIO between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ARCA biopharma, Inc.

FiledFormInsiderReported transactionsSource
2024-08-304Ma-Weaver JacobOther (J): 6,000 (derivative) · Other (J): 6,000 (derivative) · Other (J): 12,000 (derivative)EDGAR
2024-08-204JANUS HENDERSON GROUP PLC — 10% owner
Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner
Purchase (P): 5,390 @ $2.93 · Purchase (P): 428 @ $2.98EDGAR
2024-07-264JANUS HENDERSON GROUP PLC — 10% owner
Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner
Purchase (P): 165,000 @ $3.20 · Purchase (P): 17,800 @ $3.18 · Purchase (P): 7,056 @ $3.16 · Purchase (P): 30,227 @ $3.05EDGAR
2024-07-124JANUS HENDERSON GROUP PLC — 10% owner
Janus Henderson Biotech Innovation Master Fund Ltd — 10% owner
Purchase (P): 166,042 @ $3.55 · Purchase (P): 23,326 @ $3.43 · Purchase (P): 5,000 @ $3.41 · Purchase (P): 29,892 @ $3.41 · Purchase (P): 17,600 @ $3.54 · Purchase (P): 16,917 @ $3.43 · +3 moreEDGAR
2024-01-314Flynn James P — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314Ma-Weaver Jacob — Director, 10% ownerGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314Woosley Raymond L. — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314Grais Linda — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314Hove Anders D — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314MITCHELL DANIEL J — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2024-01-314CONWAY ROBERT E — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-194Flynn James P — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-12-194Funicular Funds, LP — 10% owner
Ma-Weaver Jacob — Director, 10% owner
Option exercise/expiry (X): 1,420,000 @ $2.50 · Grant/award (A): 6,000 (derivative) @ $0 · Option exercise/expiry (X): 14,200 (derivative) @ $0 · Code (E): 300 (derivative) @ $0EDGAR
2022-12-194Woosley Raymond L. — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-194Grais Linda — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-194Hove Anders D — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-194CONWAY ROBERT E — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-194MITCHELL DANIEL J — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2022-12-094Dekker C. Jeffrey — Chief Financial OfficerGrant/award (A): 40,000 @ $0EDGAR
2022-12-094Keuer Thomas A — Chief Operating OfficerGrant/award (A): 40,000 @ $0EDGAR
2022-07-084Funicular Funds, LP — 10% ownerOther (J): 2,580,452 @ $0 · Other (J): 2,580,452 @ $0 · Other (J): 14,500 (derivative) @ $0 · Other (J): 14,500 (derivative) @ $0EDGAR
2022-06-214Ma-Weaver Jacob — Director, 10% ownerGrant/award (A): 12,000 (derivative) @ $0EDGAR
2022-05-254Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 2,301 @ $2.29 · Purchase (P): 18,110 @ $2.29 · Purchase (P): 64,851 @ $2.32EDGAR
2022-05-204Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 13,072 @ $2.30 · Purchase (P): 1 @ $2.25EDGAR
2022-05-164Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 27,922 @ $2.27 · Purchase (P): 14,000 @ $2.29 · Purchase (P): 42,914 @ $2.30EDGAR
2022-05-114Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 20,979 @ $2.28 · Purchase (P): 24,596 @ $2.29EDGAR
2022-05-094Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 16,903 @ $2.27 · Purchase (P): 57,998 @ $2.28 · Purchase (P): 49,221 @ $2.27EDGAR
2022-05-024Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 23,381 @ $2.32 · Purchase (P): 8,974 @ $2.30 · Purchase (P): 1,259 @ $2.31EDGAR
2022-04-274Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 13,751 @ $2.29 · Sale (S): 7,500 (derivative) @ $64EDGAR
2022-04-204Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 9,119 @ $2.31 · Sale (S): 7,000 (derivative) @ $64EDGAR
2022-04-144Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 17,410 @ $2.33EDGAR
2022-04-124Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 30,660 @ $2.31 · Purchase (P): 4,655 @ $2.31 · Purchase (P): 69,398 @ $2.32EDGAR
2022-04-074Funicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 49,728 @ $2.30 · Purchase (P): 26,806 @ $2.30 · Purchase (P): 27,450 @ $2.32EDGAR
2022-04-074/AFunicular Fund, LP
Ma-Weaver Jacob
Purchase (P): 122,342 @ $2.26EDGAR
2022-04-044Funicular Fund, LPPurchase (P): 122,342 @ $2.26EDGAR
2021-12-164Dekker C. Jeffrey — Chief Financial OfficerGrant/award (A): 17,700 (derivative) @ $0EDGAR
2021-12-164Ozeroff Christopher David — S.V.P., General CounselGrant/award (A): 27,500 (derivative) @ $0EDGAR
2021-12-164Keuer Thomas A — Chief Operating OfficerGrant/award (A): 35,000 (derivative) @ $0EDGAR
2021-12-164BRISTOW MICHAEL R — Pres. & Chief Executive Offic, DirectorGrant/award (A): 95,000 (derivative) @ $0EDGAR
2021-11-234Ozeroff Christopher David — S.V.P., General CounselPurchase (P): 50,000 @ $2.26EDGAR
2021-05-134CONWAY ROBERT E — DirectorPurchase (P): 10,000 @ $3.19EDGAR
2021-05-064CONWAY ROBERT E — DirectorPurchase (P): 10,000 @ $3.23EDGAR
2021-01-134Woosley Raymond L. — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2021-01-134Grais Linda — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2021-01-134Hove Anders D — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2021-01-134CONWAY ROBERT E — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2021-01-134MITCHELL DANIEL J — DirectorGrant/award (A): 12,000 (derivative) @ $0EDGAR
2020-12-234Ozeroff Christopher David — S.V.P., General CounselGrant/award (A): 55,000 (derivative) @ $0EDGAR
2020-12-234Keuer Thomas A — Chief Operating OfficerGrant/award (A): 70,000 (derivative) @ $0EDGAR
2020-12-234BRISTOW MICHAEL R — Pres. & Chief Executive Offic, DirectorGrant/award (A): 190,000 (derivative) @ $0EDGAR

Recent 8-K events — ARCA biopharma, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-10-268-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-248-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-048-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-018-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-308-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2025-12-118-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2025-09-228-K1.01 — Entry into a Material Definitive Agreement
3.02 — Unregistered Sales of Equity Securities
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2025-07-018-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ABIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs